Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Nov;7(11):3978-84.
doi: 10.1128/mcb.7.11.3978-3984.1987.

The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway

Affiliations

The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway

J Papkoff et al. Mol Cell Biol. 1987 Nov.

Abstract

The int-1 proto-oncogene encodes a primary product of 370 amino acids, is normally expressed in mid-gestational embryos and adult testis, and is activated by proviral insertions during mammary carcinogenesis. Polyclonal and monoclonal antibodies directed against int-1-specific synthetic peptides immunoprecipitate up to five forms of int-1 protein, ranging in size from 36,000 to 44,000 Mr, from cell lines that express cloned int-1 DNA introduced by transfection or infection with retroviral vectors. Pulse-chase labeling experiments and glycosidase digestions suggested that the smallest of the int-1 proteins is the primary translation product lacking its signal peptide and that it is modified to produce the larger species of sequential glycosylation. Subcellular fractionations demonstrated that all immunoprecipitable forms of int-1 are mainly associated with membranes. int-1 proteins in crude microsomal preparations are resistant to proteolysis and extractable at elevated pH, suggesting that they are sequestered within cytoplasmic vesicles in a manner consistent with the behavior of secretory products. However, we were unable to identify secreted int-1 products in extracellular fluids.

PubMed Disclaimer

References

    1. J Virol. 1974 Sep;14(3):421-9 - PubMed
    1. J Supramol Struct. 1973;1(3):220-32 - PubMed
    1. Virology. 1977 Feb;76(2):539-53 - PubMed
    1. Dev Biol. 1977 APR;56(2):227-40 - PubMed
    1. Cell. 1977 Dec;12(4):893-900 - PubMed

Publication types